Nov. 17, 2020—Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research.
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Oct. 27, 2020—Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases.
Sep. 22, 2020—Vanderbilt researchers have been awarded a National Science Foundation Convergence Accelerator 2020 Cohort Phase 1 grant to create a standardized platform that will streamline the development, testing and dissemination of technology that can improve human health. The nine-month project, “Scalable, Traceable AI for Imaging Translation: Innovation to Implementation for Accelerated Impact (STRAIT I3),” looks specifically...
Tiny tweezer developed at Vanderbilt can trap molecules on a nanoscale, creating powerful research capabilities into cancer metastasis, neurodegenerative diseases
Aug. 31, 2020—Working on a minuscule scale, a new nanotweezer successfully captures and sorts individual proteins and DNA without harming their function, for myriad applications in life science research.
Aug. 28, 2020—Single-cell and multisystem analysis leads cell biologists at Vanderbilt to new understanding of rare cells, with potential inflammation-reducing therapeutics for Crohn’s disease and IBD patients.
Aug. 19, 2020—A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely.
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
Jul. 9, 2020—To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time.
Jul. 6, 2020—Vanderbilt University is ranked 36th in a 2019 U.S. patents report released by the by the National Academy of Inventors and the Intellectual Property Owners Association.
Nov. 14, 2019—A new continuum robot designed by Vanderbilt engineers achieves multiscale motion and may open up a huge world of previously impossible complex microsurgeries.
Oct. 28, 2019—An optical imaging technology developed by Orrin H. Ingram Professor of Biomedical Engineering Anita Mahadevan-Jansen and her group, in partnership with a medical device company, has been selected as a finalist for the 2019 R&D 100 Awards.
Oct. 21, 2019—Soldiers from the 3rd Brigade Combat Team of the 101st Airborne Division at Fort Campbell, Kentucky, and researchers at Vanderbilt's School of Engineering are building a partnership to identify and solve tactical problems with soldier-inspired solutions.
Jul. 18, 2019—Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.